Hyundai Bioscience Company Description

Hyundai Bioscience Co., Ltd. operates as a biotechnology company.

The company provides Vitabrid C12, a vitamin C product that delivers active vitamin C into the skin. It develops Polytaxel, a drug for pancreatic cancer and solid tumors; and CP-COV03 drug for Covid 19.

The company was founded in 2000 and is based in Seoul, South Korea.

Hyundai Bioscience Co., Ltd.

Country	South Korea
Founded	2000
Industry	Perfumes, Cosmetics, and Other Toilet Preparations
Employees	54

Contact Details

Address: 150, Bugahyeon-ro Seoul, Gyeongsangbuk-do 03759 South Korea
Phone	82 1 544 3194
Website	hyundaibioscience.com

Stock Details

Ticker Symbol	048410
Exchange	KOSDAQ
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	KRW
SIC Code	2844